Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Christopher J L Murray, Lisa Bridgett, Theo Vos et al.|The Lancet|2012Cited by 9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Theo Vos, Simon Brooker, Abraham D Flaxman et al.|The Lancet|2012Cited by 8.4k
Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the regionMaría Eugenia Grillet, Belkisyolé Alarcón-de Noya, Gabriella Blohm et al.|The Lancet Infectious Diseases|2019Cited by 225
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?Klodeta Kura, Luc E. Coffeng, Wilma A. Stolk et al.|Clinical Infectious Diseases|2024Cited by 14
How Does Treatment Coverage and Proportion Never Treated Influence the Success of <i>Schistosoma mansoni</i> Elimination as a Public Health Problem by 2030?Klodeta Kura, Roy M. Anderson, Nyamai Mutono et al.|Clinical Infectious Diseases|2024Cited by 7